Axogen, Inc. Operating Lease, Liability, Current
Axogen, Inc. (AXGN) had Operating Lease, Liability, Current of $1.96 million as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Notes › Leases › Assets and Liabilities, Lessee
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2026-07-29
- 2026-06-30: Operating Lease, Liability, Current $1.96M.
- 2026-03-31: Operating Lease, Liability, Current $2.10M.
- 2025-12-31: Operating Lease, Liability, Current $2.35M.
- 2025-09-30: Operating Lease, Liability, Current $2.33M.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2026-06-30 | $1.96M 10-Q · filed 2026-07-29 |
| 2026-03-31 | $2.10M 10-Q · filed 2026-04-28 |
| 2025-12-31 | $2.35M 10-Q · filed 2026-07-29 |
| 2025-09-30 | $2.33M 10-Q · filed 2025-10-29 |
| 2025-06-30 | $2.20M 10-Q · filed 2025-08-05 |
| 2025-03-31 | $2.08M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $1.96M 10-K · filed 2026-02-24 |
| 2024-09-30 | $1.85M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $1.75M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $1.64M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $1.54M 10-K · filed 2025-02-26 |
| 2023-09-30 | $1.09M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $1.03M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $1.04M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $1.30M 10-K · filed 2024-03-05 |
| 2022-09-30 | $1.52M 10-Q · filed 2022-11-08 |
| 2022-03-31 | $2.06M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $1.82M 10-K · filed 2023-03-14 |
| 2021-09-30 | $1.66M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $1.77M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $1.43M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $846.00K 10-K · filed 2022-02-25 |
| 2020-09-30 | $2.48M 10-Q · filed 2020-10-30 |
| 2020-06-30 | $1.54M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $1.77M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $1.72M 10-K · filed 2021-03-01 |
| 2019-09-30 | $1.75M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $1.81M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $1.34M 10-Q · filed 2019-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |